Alnylam Pharmaceuticals : Q1 2026 GAAP/Non-GAAP Reconciliation ›

Published: 2026-05-04 17:28:16 ET ALNY

Published on 05/04/2026 at 05:28 pm EDT

1

Reconciliation of Selected GAAP Measures to Non-GAAP Measures

(In thousands)

Please note that the figures presented above may not sum exactly due to rounding 2

Reconciliation of Product Revenue and Growth at Constant Currency

Constant Currency = Constant Exchange Rate, or CER 3

Disclaimer

Alnylam Pharmaceuticals Inc. published this content on May 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 04, 2026 at 21:24 UTC.